Literature DB >> 24486518

⁹⁹mTc carbonyl DTPA-rituximab: preparation and preliminary bioevaluation.

Usha Pandey1, Mythili Kameswaran1, Haladhar Dev Sarma2, Grace Samuel3.   

Abstract

The anti CD20 antibody Rituximab was conjugated with para isothiocyanato benzyl diethylene triamine penta acetic acid (p-NCS-Bz-DTPA) and subsequent radiolabeling with (99m)Tc was carried out via the (99m)Tc carbonyl synthon. The (99m)Tc labeled antibody conjugate exhibited >95% radiochemical purity after purification and retained good in vitro stability when studied up to 24h at room temperature. In vitro cell binding studies carried out in Raji cells expressing CD20 antigen validated the biological efficacy of the preparation.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  (99m)Tc carbonyl–DTPA–Rituximab; Non-Hodgkin's lymphoma (NHL); Radioimmunoscintigraphy; Rituximab

Mesh:

Substances:

Year:  2014        PMID: 24486518     DOI: 10.1016/j.apradiso.2013.12.036

Source DB:  PubMed          Journal:  Appl Radiat Isot        ISSN: 0969-8043            Impact factor:   1.513


  3 in total

Review 1.  CD20-targeting in B-cell malignancies: novel prospects for antibodies and combination therapies.

Authors:  Yaghoub Safdari; Vahideh Ahmadzadeh; Safar Farajnia
Journal:  Invest New Drugs       Date:  2016-04-13       Impact factor: 3.850

2.  Anti-CD20 Immunoglobulin G Radiolabeling with a 99mTc-Tricarbonyl Core: In Vitro and In Vivo Evaluations.

Authors:  Hélène Carpenet; Armelle Cuvillier; Jacques Monteil; Isabelle Quelven
Journal:  PLoS One       Date:  2015-10-06       Impact factor: 3.240

3.  Preparation study of indocyanine green-rituximab: A new receptor-targeted tracer for sentinel lymph node in breast cancer.

Authors:  Bin-Bin Cong; Xiao Sun; Xian-Rang Song; Yan-Bing Liu; Tong Zhao; Xiao-Shan Cao; Peng-Fei Qiu; Chong-Lin Tian; Jin-Ming Yu; Yong-Sheng Wang
Journal:  Oncotarget       Date:  2016-07-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.